Department of Human and Molecular Genetics, School of Medicine, Virginia Commonwealth University, Richmond, VA 23298-0565, USA.
Department of Pathology and Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman 11942, Jordan.
Genes (Basel). 2021 Apr 19;12(4):593. doi: 10.3390/genes12040593.
Whole Exome Sequencing (WES) is a powerful approach for detecting sequence variations in the human genome. The aim of this study was to investigate the genetic defects in Jordanian patients with inherited retinal dystrophies (IRDs) using WES. WES was performed on proband patients' DNA samples from 55 Jordanian families. Sanger sequencing was used for validation and segregation analysis of the detected, potential disease-causing variants (DCVs). Thirty-five putatively causative variants (6 novel and 29 known) in 21 IRD-associated genes were identified in 71% of probands (39 of the 55 families). Three families showed phenotypes different from the typically reported clinical findings associated with the causative genes. To our knowledge, this is the largest genetic analysis of IRDs in the Jordanian population to date. Our study also confirms that WES is a powerful tool for the molecular diagnosis of IRDs in large patient cohorts.
全外显子组测序(WES)是一种强大的方法,可用于检测人类基因组中的序列变异。本研究旨在使用 WES 研究约旦遗传性视网膜病变(IRDs)患者的遗传缺陷。对 55 个约旦家系的先证者患者 DNA 样本进行 WES 分析。对检测到的潜在致病变异(DCVs)进行 Sanger 测序验证和分离分析。在 71%的先证者(55 个家系中的 39 个)中发现了 21 个与 IRD 相关基因中的 35 个可能的致病变异(6 个新的和 29 个已知的)。三个家系的表型与相关基因的典型报道临床发现不同。据我们所知,这是迄今为止对约旦人群中 IRD 的最大遗传分析。我们的研究还证实,WES 是对大患者队列中 IRD 进行分子诊断的有力工具。